The myleoid and macrophage intrusion will be something addressed in future trials but I think with this team continuing research we will see a cure in the next few years. Liau said patients that got DCVax alone are seeing 5 year+ survival. The fat tail. So DCVax, being key to the combination approach, will be acquired in a buyout. There's no other logical explanation given the rush to patent that process.